153 related articles for article (PubMed ID: 37692262)
1. Molecular profiling of allergen-antibody IgE might decide about the efficacy of allergen immunotherapy in a patient with atopic dermatitis and allergy to house dust mites.
Bogacz-Piaseczyńska A; Bożek A; Pastuszczak M; Zalejska-Fiolka J
Postepy Dermatol Alergol; 2023 Aug; 40(4):542-547. PubMed ID: 37692262
[TBL] [Abstract][Full Text] [Related]
2. The Effectiveness of Allergen Immunotherapy in Adult Patients with Atopic Dermatitis Allergic to House Dust Mites.
Bogacz-Piaseczyńska A; Bożek A
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676639
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of molecular profiling of allergen-antibody responses in HDM-immunotherapy patients.
Nittner-Marszalska M; Kopeć A; Foks-Ciekalska A; Lata A; Bogacz-Piaseczyńska A; Rosiek-Biegus M; Zajac M; Bożek A
Hum Vaccin Immunother; 2022 Dec; 18(7):2148815. PubMed ID: 36444880
[TBL] [Abstract][Full Text] [Related]
4. Allergen-specific immunotherapy improves alopecia totalis in a severe atopic dermatitis patient.
Kwon IJ; Park JW; Kim SM; Lee KH; Park CO
J Dermatol; 2023 Oct; 50(10):1353-1356. PubMed ID: 37248786
[TBL] [Abstract][Full Text] [Related]
5. Allergen-specific immunotherapy for patients with atopic dermatitis sensitized to animal dander.
Chu H; Park KH; Kim SM; Lee JH; Park JW; Lee KH; Park CO
Immun Inflamm Dis; 2020 Jun; 8(2):165-169. PubMed ID: 32162849
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial.
Langer SS; Cardili RN; Melo JML; Ferriani MPL; Moreno AS; Dias MM; Bueno-Filho R; Pocente RHC; Roxo-Junior P; Silva J; Valera FCP; Coelho EB; Galvão CES; Carmona F; Aragon DC; Arruda LK
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):539-549.e7. PubMed ID: 34767999
[TBL] [Abstract][Full Text] [Related]
7. Specific IgE and IgG4 Profiles of House Dust Mite Components in Allergen-Specific Immunotherapy.
Yang L; Yang Y; Xu Q; Zhang W; Jiang Q; Li W; Wang Y; Ma D; Lin X; Sun B; Zhu R
Front Immunol; 2021; 12():786738. PubMed ID: 35197963
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy.
Rodríguez-Domínguez A; Berings M; Rohrbach A; Huang HJ; Curin M; Gevaert P; Matricardi PM; Valenta R; Vrtala S
J Allergy Clin Immunol; 2020 Nov; 146(5):1097-1108. PubMed ID: 32298697
[TBL] [Abstract][Full Text] [Related]
9. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma.
Agache I; Lau S; Akdis CA; Smolinska S; Bonini M; Cavkaytar O; Flood B; Gajdanowicz P; Izuhara K; Kalayci O; Mosges R; Palomares O; Papadopoulos NG; Sokolowska M; Angier E; Fernandez-Rivas M; Pajno G; Pfaar O; Roberts GC; Ryan D; Sturm GJ; van Ree R; Varga EM; van Wijk RG; Yepes-Nuñez JJ; Jutel M
Allergy; 2019 May; 74(5):855-873. PubMed ID: 31095767
[TBL] [Abstract][Full Text] [Related]
10. Long-term benefit after allergen immunotherapy to HDM in elderly patients with allergic rhinitis.
Bożek A; Bogacz-Piaseczyńska A; Miodońska M; Sadowska D
Postepy Dermatol Alergol; 2023 Oct; 40(5):688-692. PubMed ID: 38028423
[TBL] [Abstract][Full Text] [Related]
11. Molecular reactivity profiling upon immunotherapy with a 300 IR sublingual house dust mite tablet reveals marked humoral changes towards major allergens.
Potapova E; Bordas-Le Floch V; Schlederer T; Vrtala S; Huang HJ; Canonica GW; Valenta R; Matricardi PM; Mascarell L
Allergy; 2022 Oct; 77(10):3084-3095. PubMed ID: 35474582
[TBL] [Abstract][Full Text] [Related]
12. Clinical effectiveness of house dust mite immunotherapy in mono- versus poly-sensitised patients with allergic rhinitis: a systematic review and meta-analysis.
Kim JY; Hwang D; Jang M; Rhee CS; Han DH
Rhinology; 2021 Aug; 59(4):352-359. PubMed ID: 34180463
[TBL] [Abstract][Full Text] [Related]
13. Mite allergy and atopic dermatitis: Is there a clear link? (Review).
Bumbacea RS; Corcea SL; Ali S; Dinica LC; Fanfaret IS; Boda D
Exp Ther Med; 2020 Oct; 20(4):3554-3560. PubMed ID: 32905207
[TBL] [Abstract][Full Text] [Related]
14. Specific IgE against the house dust mite allergens Der p 5, 20 and 21 influences the phenotype and severity of atopic diseases.
Walsemann T; Böttger M; Traidl S; Schwager C; Gülsen A; Freimooser S; Roesner LM; Werfel T; Jappe U
Allergy; 2023 Mar; 78(3):731-742. PubMed ID: 36239002
[TBL] [Abstract][Full Text] [Related]
15. House dust mites as potential carriers for IgE sensitization to bacterial antigens.
Dzoro S; Mittermann I; Resch-Marat Y; Vrtala S; Nehr M; Hirschl AM; Wikberg G; Lundeberg L; Johansson C; Scheynius A; Valenta R
Allergy; 2018 Jan; 73(1):115-124. PubMed ID: 28741705
[TBL] [Abstract][Full Text] [Related]
16. Allergen-specific immunotherapy by recombinant Der P1 allergen-derived peptide-based vaccine in an allergic mouse model.
Asoudeh Moghanloo S; Forouzanfar M; Jafarinia M; Fazlollahi MR; Kardar GA
Immun Inflamm Dis; 2023 Jun; 11(6):e878. PubMed ID: 37382249
[TBL] [Abstract][Full Text] [Related]
17. Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study.
Oosting AJ; de Bruin-Weller MS; Terreehorst I; Tempels-Pavlica Z; Aalberse RC; de Monchy JG; van Wijk RG; Bruijnzeel-Koomen CA
J Allergy Clin Immunol; 2002 Sep; 110(3):500-6. PubMed ID: 12209102
[TBL] [Abstract][Full Text] [Related]
18. Coordinated IgG2 and IgE responses as a marker of allergen immunotherapy efficacy.
Bordas-Le Floch V; Berjont N; Batard T; Varese N; O'Hehir RE; Canonica WG; van Zelm MC; Mascarell L
Allergy; 2022 Apr; 77(4):1263-1273. PubMed ID: 34551124
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis].
Huang HH; Xu C; Liu L; Chai RN
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):774-783. PubMed ID: 35785859
[No Abstract] [Full Text] [Related]
20. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study.
Cadario G; Galluccio AG; Pezza M; Appino A; Milani M; Pecora S; Mastrandrea F
Curr Med Res Opin; 2007 Oct; 23(10):2503-6. PubMed ID: 17784996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
